149 related articles for article (PubMed ID: 32865787)
1. Tips for Successful lncRNA Knockdown Using Gapmers.
Lennox KA; Behlke MA
Methods Mol Biol; 2020; 2176():121-140. PubMed ID: 32865787
[TBL] [Abstract][Full Text] [Related]
2. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides.
Lennox KA; Behlke MA
Nucleic Acids Res; 2016 Jan; 44(2):863-77. PubMed ID: 26578588
[TBL] [Abstract][Full Text] [Related]
3. Knocking Down Long Noncoding RNAs Using Antisense Oligonucleotide Gapmers.
Maruyama R; Yokota T
Methods Mol Biol; 2020; 2176():49-56. PubMed ID: 32865781
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Knockdown Activity of MALAT1 ENA Gapmers In Vitro.
Iwashita S; Shoji T; Koizumi M
Methods Mol Biol; 2020; 2176():155-161. PubMed ID: 32865789
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of nuclear-retained long noncoding RNAs using modified DNA antisense oligonucleotides.
Zong X; Huang L; Tripathi V; Peralta R; Freier SM; Guo S; Prasanth KV
Methods Mol Biol; 2015; 1262():321-31. PubMed ID: 25555591
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Silencing of lncRNAs Using LNA GapmeRs.
Taiana E; Favasuli V; Ronchetti D; Morelli E; Tassone P; Viglietto G; Munshi NC; Neri A; Amodio N
Methods Mol Biol; 2021; 2348():157-166. PubMed ID: 34160805
[TBL] [Abstract][Full Text] [Related]
7. Non-Coding RNA Silencing in Mammalian Cells by Antisense LNA GapmeRs Transfection.
Alfeghaly C; Aigueperse C; Maenner S; Behm-Ansmant I
Methods Mol Biol; 2021; 2300():31-37. PubMed ID: 33792869
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of Nuclear lncRNAs by Locked Nucleic Acid (LNA) Gapmers in Nephron Progenitor Cells.
Nishikawa M; Yanagawa N
Methods Mol Biol; 2020; 2161():29-36. PubMed ID: 32681503
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Long Noncoding RNA Plasmacytoma Variant Translocation 1 with Antisense Locked Nucleic Acid GapmeRs Exerts Tumor-Suppressive Functions in Human Acute Erythroleukemia Cells Through Downregulation of
Salehi M; Sharifi M; Bagheri M
Cancer Biother Radiopharm; 2019 Aug; 34(6):371-379. PubMed ID: 30141968
[No Abstract] [Full Text] [Related]
10. Antisense Oligonucleotide-Mediated Transcript Knockdown in Zebrafish.
Pauli A; Montague TG; Lennox KA; Behlke MA; Schier AF
PLoS One; 2015; 10(10):e0139504. PubMed ID: 26436892
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of Nuclear-Located Enhancer RNAs and Long ncRNAs Using Locked Nucleic Acid GapmeRs.
Roux BT; Lindsay MA; Heward JA
Methods Mol Biol; 2017; 1468():11-8. PubMed ID: 27662866
[TBL] [Abstract][Full Text] [Related]
12. Antisense Oligonucleotides as a Tool for Prolonged Knockdown of Nuclear lncRNAs in Human Cell Lines.
Montiel-Manriquez R; Castro-Hernández C; Arriaga-Canon C; Herrera LA
J Vis Exp; 2023 Sep; (199):. PubMed ID: 37677025
[TBL] [Abstract][Full Text] [Related]
13. The choice of negative control antisense oligonucleotides dramatically impacts downstream analysis depending on the cellular background.
Ducoli L; Agrawal S; Hon CC; Ramilowski JA; Sibler E; Tagami M; Itoh M; Kondo N; Abugessaisa I; Hasegawa A; Kasukawa T; Suzuki H; Carninci P; Shin JW; de Hoon MJL; Detmar M
BMC Genom Data; 2021 Sep; 22(1):33. PubMed ID: 34521352
[TBL] [Abstract][Full Text] [Related]
14. Use of GapmeRs for gene expression knockdowns in human primary resting CD4+ T cells.
Abewe H; Deshmukh S; Mukim A; Beliakova-Bethell N
J Immunol Methods; 2020 Jan; 476():112674. PubMed ID: 31629740
[TBL] [Abstract][Full Text] [Related]
15. GapmeR-Mediated Gene Silencing in Motile T-Cells.
Fazil MHUT; Ong ST; Chalasani MLS; Kizhakeyil A; Verma NK
Methods Mol Biol; 2019; 1930():67-73. PubMed ID: 30610600
[TBL] [Abstract][Full Text] [Related]
16. Characterization of target mRNA reduction through in situ RNA hybridization in multiple organ systems following systemic antisense treatment in animals.
Hung G; Xiao X; Peralta R; Bhattacharjee G; Murray S; Norris D; Guo S; Monia BP
Nucleic Acid Ther; 2013 Dec; 23(6):369-78. PubMed ID: 24161045
[TBL] [Abstract][Full Text] [Related]
17. RNA Reduction and Hepatotoxic Potential Caused by Non-Gapmer Antisense Oligonucleotides.
Hori SI; Mitsuoka Y; Kugimiya A
Nucleic Acid Ther; 2019 Feb; 29(1):44-50. PubMed ID: 30508397
[TBL] [Abstract][Full Text] [Related]
18. Role of Computationally Evaluated Target Specificity in the Hepatotoxicity of Gapmer Antisense Oligonucleotides.
Kasuya T; Kugimiya A
Nucleic Acid Ther; 2018 Oct; 28(5):312-317. PubMed ID: 30095329
[TBL] [Abstract][Full Text] [Related]
19. Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.
Amodio N; Stamato MA; Juli G; Morelli E; Fulciniti M; Manzoni M; Taiana E; Agnelli L; Cantafio MEG; Romeo E; Raimondi L; Caracciolo D; Zuccalà V; Rossi M; Neri A; Munshi NC; Tagliaferri P; Tassone P
Leukemia; 2018 Sep; 32(9):1948-1957. PubMed ID: 29487387
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth.
Michalik KM; You X; Manavski Y; Doddaballapur A; Zörnig M; Braun T; John D; Ponomareva Y; Chen W; Uchida S; Boon RA; Dimmeler S
Circ Res; 2014 Apr; 114(9):1389-97. PubMed ID: 24602777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
